Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12428227rdf:typepubmed:Citationlld:pubmed
pubmed-article:12428227lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C0039099lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C0600210lld:lifeskim
pubmed-article:12428227lifeskim:mentionsumls-concept:C1511636lld:lifeskim
pubmed-article:12428227pubmed:issue11lld:pubmed
pubmed-article:12428227pubmed:dateCreated2002-11-12lld:pubmed
pubmed-article:12428227pubmed:abstractTextRheumatoid arthritis (RA) is characterized by chronic inflammation of multiple joints. Large numbers of T cells, which produce type 1 cytokines, infiltrate into RA synovium. Chemokines and chemokine receptors are considered to contribute to the T cell infiltration. In this study, we examined the role of CX3CL1/fractalkine and its receptor CX3C chemokine receptor 1 (CX3CR1) in the T cell migration into RA synovium.lld:pubmed
pubmed-article:12428227pubmed:languageenglld:pubmed
pubmed-article:12428227pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12428227pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12428227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12428227pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12428227pubmed:statusMEDLINElld:pubmed
pubmed-article:12428227pubmed:monthNovlld:pubmed
pubmed-article:12428227pubmed:issn0004-3591lld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:ImaiToshioTlld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:MiyasakaNobuy...lld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:YoshieOsamuOlld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:TaniguchiKenKlld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:HasegawaJunJlld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:NankiToshihir...lld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:HayashidaKenj...lld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:NagasakaKenji...lld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:UrasakiYasuyo...lld:pubmed
pubmed-article:12428227pubmed:authorpubmed-author:NonomuraYoshi...lld:pubmed
pubmed-article:12428227pubmed:issnTypePrintlld:pubmed
pubmed-article:12428227pubmed:volume46lld:pubmed
pubmed-article:12428227pubmed:ownerNLMlld:pubmed
pubmed-article:12428227pubmed:authorsCompleteYlld:pubmed
pubmed-article:12428227pubmed:pagination2878-83lld:pubmed
pubmed-article:12428227pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:meshHeadingpubmed-meshheading:12428227...lld:pubmed
pubmed-article:12428227pubmed:year2002lld:pubmed
pubmed-article:12428227pubmed:articleTitleMigration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.lld:pubmed
pubmed-article:12428227pubmed:affiliationDepartment of Bioregulatory Medicine and Rheumatology, Graduate School, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. nanki.rheu@tmd.ac.jplld:pubmed
pubmed-article:12428227pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12428227pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12428227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12428227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12428227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12428227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12428227lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12428227lld:pubmed